Lexogen in Tune with Nature
28. February 2023
The best ideas don’t always come from outside the box Sometimes they are the box! Introducing Lexogen New Packaging with Modular Design Better for the planet 100% biodegradable 100% recyclable
News
Read More ›
Make your short film a Winner with Lexogen 15th Anniversary!
4. July 2022
Make your short film a Winner with Lexogen 15th Anniversary! Join our Short Film Competition (open to all*) and win great prizes up to 2000 € * disclaimer related to
Lexogen Solutions for SARS-CoV-2 Whole Genome Sequencing
8. July 2021
Through the continued threat of COVID-19, the need for reliable methods to detect and trace viral variants is constantly increasing. Surveillance monitoring of the SARS-CoV-2 genome is required to identify
mRNA sequencing with CORALL
13. January 2021
Lexogen now offers CORALL mRNA-Seq bundles including poly(A) selection providing a convenient complete workflow solution for mRNA-Seq library preparation. Features and Benefits CORALL mRNA-Seq features an easy all-in-one workflow from
RNA Society and RNA Expert Lexogen Continue Their Successful RNA Salon Collaboration to Support Thousands of Researchers World-Wide
19. November 2020
In 2020, the molecule RNA (ribonucleic acid) has moved into the center of worldwide attention with the COVID 19 pandemic caused by the RNA-based SARS-CoV-2 virus. RNA is highly versatile,
COVID-19: a solution exists to prevent lockdowns and economic collapse!
17. November 2020
Mass screening is the best solution to master the pandemic, prevent lockdown and come back to normality. This strategy will always pay-off even when a vaccine will be available as
Upgrade of RiboCop rRNA Depletion Kit and Launch of Combined rRNA & Globin Depletion Kit
21. September 2020
Total RNA is comprised of large amounts of undesired transcripts, such as ribosomal RNA (rRNA), which account for ~80-98 % of the total RNA sample, and globin mRNA, accounting for
Minister for Digital and Economic Affairs Dr. Margarete Schramböck visited Lexogen
4. September 2020
This week the Austrian Minister for Digital and Economic Affairs Dr. Margarete Schramböck accompanied by Managing Director of the FFG Dr. Henrietta Egerth visited Lexogen’s headquarters in Vienna to inform
Lexogen Launches the New QuantSeq-Pool Kit to Accelerate Digital Gene Expression Profiling Projects
19. August 2020
Vienna, Austria, August 19, 2020 – Today Lexogen, the transcriptomics and next-generation sequencing company, announced the launch of the QuantSeq-Pool Sample-Barcoded 3’ mRNA-Seq Library Prep Kit. The QuantSeq-Pool method combines
Lexogen Appoints Stéphane Barges as New CEO
4. August 2020
Vienna, Austria, August 4, 2020 – Today Lexogen, the transcriptomics and next-generation sequencing company, announced that Stéphane Barges, PhD, MBA has been appointed as new Chief Executive Officer effective from
Categories
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast and Great Lakes:
+1 312-978-6413
California:
+1 415-726-4318
Rest of the Country:
+1 615-968-3325
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Cart
Product
Product Short Description
PRICE
Product
Product Short Description
PRICE
Product
Product Short Description
PRICE